BPA Call 36C25621A0025-36C25624N0222

Diagnostica Stago Inc., a foreign-owned medical device manufacturer specializing in hemostasis and thrombosis testing technologies, received a Blanket Purchase Agreement (BPA) call award from Veterans Integrated Service Network (VISN) 16 on October 1, 2023, with a ceiling value of $147,138.82 and an ultimate completion date of September 30, 2024. The contract, issued under GSA Schedule 66-III for Critical Analyzers and Laboratory Equipment and Supplies, provides coagulation testing instrumentation, reagents, and supplies to support clinical laboratory operations at VA medical facilities. No set-aside designation was used in this open competition award. Diagnostica Stago's STA series of hemostasis analyzers and associated consumables enable healthcare professionals at VA facilities to conduct specialized coagulation assessments, including prothrombin time, partial thromboplastin time, fibrinogen, and D-dimer testing, which are essential for evaluating bleeding disorders, clotting factor deficiencies, and anticoagulation therapy management.

This BPA call represents a task order under Diagnostica Stago's larger Blanket Purchase Agreement vehicles with the Department of Veterans Affairs, which include significant agreements with multiple VISNs, such as a $3.5 million BPA with VISN 6 and a $3.9 million BPA with VISN 17. The company's established presence in the federal healthcare market, with SAM registration dating to November 2001, demonstrates its consistent ability to deliver critical diagnostic capabilities to VA medical centers and other federal healthcare agencies. The Firm Fixed Price arrangement reflects standard commercial pricing for coagulation testing products and services critical to patient care and diagnostic operations across the Veterans Health Administration network.